229 Results

People

  1. Cordon-Cardo
    Cordon-Cardo
  2. Old
    Old
  3. Adusumilli
    Adusumilli
  4. Cheung
    Cheung
  5. De Stanchina
    De Stanchina
  6. Hollmann
    Hollmann
  7. Oettgen
    Oettgen
  8. Powell
    Powell
  9. Reis-Filho
    Reis-Filho
  10. Weigelt
    Weigelt

Groups

  1. GSK Faculty (81)
  2. Sloan Kettering Institute Postdocs (66)
  3. Sloan Kettering Institute Faculty (59)
  4. Department of Medicine (48)
  5. Surgery (34)
  6. Department of Pathology and Laboratory Medicine (33)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)
  8. Solid Tumor Oncology Division (25)
  9. Tow Center for Developmental Oncology (TCDO) (23)
  10. Center for Molecular Imaging and Biotechnology (19)
  1. "immunofluorescence"
Formats
  1. Journal Article (217)
  2. Review (7)
  3. Editorial (3)
  4. Conference Paper (1)
  5. Research Letter (1)
Groups
  1. GSK Faculty (81)
  2. Sloan Kettering Institute Postdocs (66)
  3. Sloan Kettering Institute Faculty (59)
  4. Department of Medicine (48)
  5. Surgery (34)
  6. Department of Pathology and Laboratory Medicine (33)

More Groups

People
  1. Carlos Cordon-Cardo (9)
  2. Lloyd Old (8)
  3. Britta Weigelt (5)
  4. Elisa De Stanchina (5)
  5. Herbert Oettgen (5)
  6. Jorge Reis-Filho (5)

More People

Years
  1. 2025 (19)
  2. 2024 (34)
  3. 2023 (13)
  4. 2022 (9)
  5. 2021 (7)
  6. 2020 (10)

More Years

Publications
  1. Cancer Research (10)
  2. Nature (10)
  3. Journal for ImmunoTherapy of Cancer (7)
  4. Journal of Experimental Medicine (7)
  5. Blood (6)
  6. Cancer Discovery (6)

More Publications

Publishers
  1. Nature Publishing Group (23)
  2. American Association for Cancer Research (22)
  3. Elsevier Inc. (15)
  4. Cell Press (14)
  5. Rockefeller University Press (11)
  6. Lippincott Williams & Wilkins (9)

More Publishers

Results (229)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
    Journal Article

    Quintanal-Villalonga, Á; Ferrer, I.; Guruceaga, E.; Cirauqui, C.; Marrugal, Á; Ojeda, L.; García, S.; Zugazagoitia, J.; Muñoz-Galván, S.; Lopez-Rios, F.; more...
    EBioMedicine (2020)

    Fulltext@MSK | Save
  • Evaluation of the predictive role of tumor immune infiltrate in patients with HER2-positive breast cancer treated with neoadjuvant anti-HER2 therapy without chemotherapy
    Journal Article

    De Angelis, C.; Nagi, C.; Hoyt, C. C.; Liu, L.; Roman, K.; Wang, C.; Zheng, Y.; Veeraraghavan, J.; Sethunath, V.; Nuciforo, P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • P2RY8-CRLF2 fusion–positive acute myeloid leukemia with myelodysplasia-related changes: Response to novel therapy
    Journal Article

    Aypar, U.; Taylor, J.; Garcia, J. S.; Momeni-Boroujeni, A.; Gao, Q.; Baik, J.; Londono, D.; Benayed, R.; Sigler, A.; Haddadin, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Glutamine independence is a selectable feature of pluripotent stem cells
    Research Letter

    Vardhana, S. A.; Arnold, P. K.; Rosen, B. P.; Chen, Y.; Carey, B. W.; Huangfu, D.; Carmona-Fontaine, C.; Thompson, C. B.; Finley, L. W. S.
    Nature Metabolism (2019)

    Fulltext@MSK | Save
  • Developmental origin, functional maintenance and genetic rescue of osteoclasts
    Journal Article

    Jacome-Galarza, C. E.; Percin, G. I.; Muller, J. T.; Mass, E.; Lazarov, T.; Eitler, J.; Rauner, M.; Yadav, V. K.; Crozet, L.; Bohm, M.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • DNA-enabled rational design of fluorescence-Raman bimodal nanoprobes for cancer imaging and therapy
    Journal Article

    Pal, S.; Ray, A.; Andreou, C.; Zhou, Y.; Rakshit, T.; Wlodarczyk, M.; Maeda, M.; Toledo-Crow, R.; Berisha, N.; Yang, J.; more...
    Nature Communications (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • Phf6 loss enhances HSC self-renewal driving tumor initiation and leukemia stem cell activity in T-ALL
    Journal Article

    Wendorff, A. A.; Quinn, S. A.; Rashkovan, M.; Madubata, C. J.; Ambesi-Impiombato, A.; Litzow, M. R.; Tallman, M. S.; Paietta, E.; Paganin, M.; Basso, G.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Methods to study the role of progranulin in the tumor microenvironment
    Journal Article

    Elkabets, M.; Brook, S.
    Methods in Molecular Biology (2018)

    Fulltext@MSK | Save
  • VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells
    Journal Article

    Khan, A. J.; Misenko, S. M.; Thandoni, A.; Schiff, D.; Jhawar, S. R.; Bunting, S. F.; Haffty, B. G.
    Oncotarget (2018)

    Fulltext@MSK | Save